Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

À§¿¡ ¹ß»ýÇÑ ÆíÆò»óÇǼ±¾Ï Gastric Adenosquamous Carcinoma

´ëÇѾÏÇÐȸÁö 1999³â 31±Ç 4È£ p.710 ~ 715
Á¤ÀçÈ£, ½Åµ¿¿î, ³ë¼ºÈÆ, ¹ÎÁø½Ä,
¼Ò¼Ó »ó¼¼Á¤º¸
Á¤ÀçÈ£ (  ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

½Åµ¿¿î (  ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
³ë¼ºÈÆ (  ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
¹ÎÁø½Ä (  ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç

Abstract

¼­·Ð
À§¾ÏÀº ¿ì¸® ³ª¶ó¿¡¼­ °¡Àå ÈçÇÑ ¾Ç¼ºÁ¾¾çÀÌ¸ç ¶ÇÇÑ Áß¿äÇÑ »ç¸Á¿øÀÎÀÌ´Ù. À§¿¡ ¹ß»ýÇÏ´Â
¾Ç¼ºÁ¾¾çÀÇ ´ëºÎºÐÀº Á¶Á÷ÇÐÀûÀ¸·Î ¼±¾ÏÀ̸ç ÆíÆò»óÇǼ±¾ÏÀº Àüü À§¾ÏÀÇ ¾à 0.5%¸¦ Â÷Áö
ÇÏ´Â ¸Å¿ì µå¹® ÁúȯÀÌ´Ù. À§¿¡ ¹ß»ýÇÏ´Â ÆíÆò»óÇǼ±¾ÏÀº 1905³â Rolleston°ú Trevor°¡ ó
À½ º¸°íÇÏ¿´À¸¸ç µ¿¾ç¿¡¼­´Â 1937³â ÀϺ»ÀÇ Takashiro¿¡ ÀÇÇØ Ã³À½ º¸°íµÈ ¹Ù ÀÖ´Ù. ±¹³»¿¡
¼­µµ À§ÆíÆò»óÇǼ±¾Ï¿¡ ´ëÇÑ º´¸®Á¶Á÷ÇÐÀû Ư¼º ¹× ÀÓ»ó¾ç»ó¿¡ ´ëÇÑ ¿¬±¸´Â µå¹® ½ÇÁ¤ÀÌ´Ù.
ÀúÀÚµéÀº º´¸®Á¶Á÷ÇÐÀûÀ¸·Î È®ÀÎµÈ À§ÆíÆò»óÇǼ±¾Ï 9¿¹ÀÇ ÀÓ»óÀû °íÂûÀ» ÅëÇØ ÀÌ ÁúȯÀÇ º´
Å»ý¸® ¹× ÀÓ»óÀû Ư¼º¿¡ ´ëÇØ ¾Ë¾Æº¸°íÀÚ ÇÑ´Ù.

Purpose : Adenosquamous carcinoma, a rare malignant tumor of the stomach, is
characterized by two different cell components, one adenomatous and the other
squamous component. Its clinicopathologic feature and prognosis are quite different from
the ordinary adenocarcinomas. We report our experience of 9 such cases.
Materials and Methods : Clinical and pathologic features were reviewed for the 9
patients who underwent gastrectomies and were confirmed as adenosquamous carcinoma
by pathologists during the 10-year period of from 1987 to 1998. Postoperative adjuvant
therapy and prognosis were also reviewed.
Results : The ages of 6 male and 3 female patients ranged from 30 to 59, with the
median age of 48. Total gastrectomy was done in 4 cases, while other underwent
subtotal gastrectomy. Curative resection was done in four cases. Fourteen additional
organs were rejected concomitantly due to suspicious tumor invasion and among them 9
organs were histologically confirmed for tumor invasion. The mean tumor size was 7.4
§¯ (2.5¡­27 §¯) and all cases were pathologically advanced. One case showed peritoneal
seeding and 3 cases showed hepatic metastases. There were 7 cases of stage ¥³ disease
by the UICC TNM classification (5th ed.) and the other two were stage ¥± and stage
¥²b respectively. Eight cases received postoperative adjuvant chemotherapy comprising
5-FU, DDP, adriamycin, picibanil or VP-16. Of 9 patients, 6 died and the overall 5-year
survival rate was 15.3%.
Conclusion : Adenosquamous cancer of stomach is regarded as a disease of
unfavorable prognosis, which was confirmed by this study. The treatments were not
quite different from those for other stomach cancers. Although more cases and further
investigations are essential for complete understanding of the clinical prognosis and
proper treatment of the gastric adenosquarnous cancer, early diagnosis, curative resection
and close postoperative follow-ups are currently available options for better outcome of
this disease.

Å°¿öµå

Adenosquamous carcinoma; Stomach;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS